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The time course, dose response, components of inflam­
mation, and involvement of putative mediators of inflam­
mation in irritation induced by different chemicals was 
compared using a mouse ear swelling technique. Differ­
ences in time courses of inflammation produced by the 
irritants were not solely due to differences in rates of pen­
etration. Changes in blood flow and permeability of vessels 
S oaps, detergents, cosmetics, pesticides, petroleum prod­ucts, and a multitude of occupational and environmental agents are recognized as potential causes of nonimmu­nologic chemically induced skin inflammation. The im­portance of chemically induced skin irritation has long 
been recognized by regulatory and industrial toxicologists. Reg­
ulatory agencies require that the risk of skin irritation be consid­
ered when commercial manufacturers develop, register, or certify 
materials, or transport chemicals [1]. Understandably, the efforts 
of most dermatotoxicologists have focused on screening chemi­
cals or combinations of chemicals by standard bioassays to predict 
effects of skin exposure in the workplace or during use by con­
sumers. The bioassays commonly used to screen chemicals for 
irritation are predominantly modifications of the Draize method 
[1,2]. Objections raised to these procedures for predictive testing 
include the use of the rabbit, clipping the hair and possible skin 
damage from clipping, use of abraded sites, occlusion of the test 
site, problems associated with securing the patch, tapes, etc., 
duration of the exposure, and the visual grading scale [3]. The 
same objections limit the use of this type of assay for studies of 
mechanisms of skin irritation. 
Pharmacologists have developed a number of assays in which 
inflammation is quantitated by less subjective means, which are 
reproducible. In one of the most widely used assays of this type, 
the Tonnelli test [4,5), a solution containing an irritant and the 
drug being investigated is applied topically to one ear of rats. 
One ear of animals in a control group is treated with the irritant 
only. In the original assay, the degree of inflammation was quan-
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were phasic with different numbers of phases induced by 
different irritants. Effects of antagonists, synthesis, inhib­
itors, and depleting agents of putative inflammatory me­
diators on intensity of inflammation varied for different 
irritants. These studies demonstrate that all chemicals do 
not produce skin irritation by a common inflammatory 
pathway. J Invest Dermatof 88:245-315, 1987 
tified as differences in wet and dry weights of treated and un­
treated ears; anti-inflammatory activity was determined by com­
paring the responses of control and drug-treated groups. The 
technique was later refmed by measuring ear thickness with a 
micrometer [6 ] to assess the degree of inflammation, and some 
investigators have used laboratory mice [7,8]. 
A rodent ear assay procedure using ear thickness to quantify 
the degree of inflammation would effectively circumvent many 
problems of the more commonly used skin irritation assays: it is 
not necessary to clip hair from the site, the site is not abraded, 
the test area is not occluded, and the response can be evaluated 
by nonvisual measurements in which the units are linear. 
PRELIMINARY WORK 
In preliminary experiments, standardized procedures for applying 
test materials, handling the animals, and measuring ear thickness 
were developed [9,10]. Five microliters of fluid could be applied 
to both the dorsal and ventral surface of the ear pinna without 
running into body hair or collecting in the base of the ear. Animals 
were conditioned to handling so that measurements could be 
made in conscious animals throughout the time course of the 
reactions. Ear thickness measurements were made with an Oditest 
spring-loaded caliper type micrometer, which was modified to 
reduce pressure applied to the tissue. Two measurements were 
taken on each ear: the first at the apex of the pinna, the second 
approximately 5 mm from the apex. Thickness of untreated ears 
at the tip of the pinna varied between 0.22 and 0.29 mm; 5 mm 
from the tip, thickness varied between 0.25 and 0.33 mm. Three 
strains of mice, ICRISW, CD-I, and BALBlc, of both sexes were 
used. Several chemicals were tested in these preliminary experi­
ments, and it was observed that the time of maximum intensity 
of inflammation varied by compound, and that the ears of animals 
treated with some irritants did not return to normal thickness. 
Possible explanations of this observation include differences in 
rates of absorption, in the mechanisms of inflamIl}ation, and in 
mechanisms of repair. 
Experiments were designed to determine if the differences ob­
served were due to differences in the underlying inflammatory 
mechanisms. Because aggressive behavior between male cage­
mates may damage the pinna, female mice were selected for those 
studies. Since the 3 strains were approximately equivalent in reac­
tivity to the irritants, ICR mice were selected because of local 
availability and ease in handling. Three phases of experiments 
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were planned: to determine if rate of absorption controlled the 
time course of the responses, to compare the components of the 
response to at least 3 irritants, and to identify mediators of the 
response to those irritants. 
RATE OF ABSORPTION 
Rate of absorption through skin depends on 2 externally deter­
mined factors, penetrant concentration and partition coefficient 
between the stratum corneum and the vehicle in which the pen­
etrant is applied, and two internal factors, a diffusion constant 
and stratum corneum thickness, i.e., the number of cell layers 
[11]. Skin thickness is not altered within the time frame of �hese 
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Figure 1. Time course and dose/response of changes in ear thickness. 
Varying doses of (a) phenol in ethanol, croton oil in (b) acetone and (c) 
olive oil, and (d) ethyl phenylpropiolate in acetone were applied to one 
ear of ICR female mice. Mean ear thickness ± SD at various times are 
shown. All doses were applied in a volume of 10 �1. 
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dose/response studies; therefore, internal factors can be consid­
ered constant. If doses of each irritant are applied in a constant 
volume of solvent, varying the dose varies penetrant concentra­
tion. Changing the solvent in which an irritant is applied alters 
the second external variable controlling rate of absorption. 
The dose/ear thickness response relationship for phenol was 
investigated by applying 5 doses of 1-2 mg solubilized in ethanol 
to the ears of groups of 8-11 ICR female mice. For all doses 
tested, inflammation peaked in intensity between 1 and 2 h (Fig 
la). Inflammation produced by phenol in water reached maxi­
mum intensity at the same time, although the response was less 
intense. 
Five doses of croton oil in olive oil, 0. 1-2.5 mg were applied 
to the ear of groups of 9-11 female ICR mice. Groups of 6 mice 
were treated with 0.01-0.2 mg croton oil in acetone. The inflam­
matory responses to the 3 higher doses in olive oil peaked in 
intensity 6-8 h after application. The intensity of the inflamma­
tory response was increased when acetone replaced olive oil as 
the vehicle. Thus in olive oil, 0.1 mg croton oil was nonirritating; 
the same dose in acetone produced an increase in thickness from 
0.276 to 0.6 98 at 6 h (Fig Ib,e). However, the response to croton 
oil applied in acetone also reached maximum 6 h after application. 
Doses of 1 and 2 mg benzalkonium chloride in ethanol were 
applied to 1 ear of 11 and 13 animals, respectively. The increase 
in ear thickness was maximal 6 h after application. 
Ear thickness became maximum 15 min after application of 
7.5, 5, or 2.5 mg methyl salicylate in ethanol; the response to 10 
mg (100%) methyl salicylate reached maximum within 30 min. 
Groups of 5 or 6 animals were treated with 2.5, 1.0, 0.05, 
0.025, and 0.01 mg ethyl phenylpropiolate (EPP) in acetone. Low 
doses of EPP produced a single inflammatory peak at 1 h (Fig 
Id). A larger second peak reached maximum 8 h after application 
of higher doses. 
Results of doselresponse studies show that time of maximum 
inflammation after topical application of irritants is not simply a 
reflection of the relative rates of absorption. Time of maximum 
inflammation was not changed by varying the amount of irritant 
applied, or by changing the solvent. The change in intensity of 
response observed as the dose was increased or when the vehicle 
Table I. Ear Responses to Different Irritants 
Mean Thickness (mm) Incidence 
at Maximum of Permanent 
Irritant/Dose' Intensityh Thickening' 
Phenol/1.0 mg 0.30 1/8 
Phenol/1.S mg 0.43 6/10 
Phenol/2.0 mg 0.67 10/10 
Benzalkonium 0.57 11/11 
chloride/1.0 mg 
Methyl salicylate/S.O mg 0.39 0/6 
Methyl salicylate17.S mg 0.46 0/5 
Croton oi1/0.2 mg in 0.66 0/6 
acetone 
Croton oil/O.OS mg in 0.59 0/6 
acetone 
Ethyl phenylpropiolate/ 0.69 0/6 
5.0 mg 
Ethyl phenylpropiolate/ 0.49 0/6 
2.0 mg 
'Phenol. benzalkonium chloride. and methyl salicylate were applied in ethanol; 
ethyl phenylpropiolate and croton oil were applied in acetone. 10/41 of the solurion 
was applied to each ear. The vehicle in which the irritant was solubifued was applied 
to the opposite ear. 
'The ear thickness listed was at maximum intensity of the response: phenol. 
1 h; benzalkonium chloride. 6 h; methyl salicylate. 15 min; croton oil. 6 h; ethyl 
phenylpropiolate. 8 h. 
'Ear thickness was monitored for 6 weeks after application of an irritant to one 
ear. The number of animals in which the irritant-treated ear was 0.05--0.1 mm 
thicker than the solvent-treated control ear is shown. 
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was changed shows that these manipulations changed the rate of 
absorption of the irritants into the tissue. 
Differences in the rate at which inflamed ears returned to nor­
mal were also noted. Ear thickness was monitored for up to 6 
weeks after application of the chemicals. Ears to which phenol 
and benzalkonium chloride had been applied remained 0.05-0.1 
mm thicker than the solvent-treated control ear of the same animal 
(Table I). The incidence of permanent thickening was dose-de­
pendent, but was not determined by the severity of the initial 
response; ears of mice treated with EPP, croton oil, or methyl 
salicylate that developed ear thickness responses of the same mag­
nitude as phenol or benzalkonium chloride did not become per­
manently thickened. 
COMPONENTS OF THE RESPONSE 
Since the time ofCelsus, 4 major signs of inflammation have been 
recognized: "rubor et tumor cum calore et dolore," redness and swell­
ing with heat and pain. In 1867, by observing changes in the 
mesentery of a live frog when exposed to air, Julius Cohnheim 
described the components of the inflammatory response that 
produce these signs [12]. Vasodilation and increased blood flow 
could account for redness and heat and the exudation of fluid for 
swelling; pain could be assumed. Cohnheim also observed infil­
tration of white blood cells into the tissue and the increased blood 
flow, increased permeability of vessels to proteins, and devel­
opment of an infiltrate of inflammatory cells that he described 
became known as the components of inflammation. 
The most comprehensive studies of the components of chem­
ically induced skin irritation were conducted by Steele and Wil­
helm [13,14] in the late 1960s. They studied dye leakage, ery­
thema, and histology of reactions to xylol, benzene, carbon 
tetrachloride, chloroform, and phenol, and outlined 3 phases of 
the responses. If the inflammation produced by these irritants 
developed by different mechanisms, one would have expected to 
see differences in the components; their results suggested that 
those chemicals acted by a common mechanism. However, they 
used visual grading for evaluating both blood flow (erythema) 
and vascular permeability (dye leakage). 
Because treatment with phenol and benzalkonium chloride 
produced reactions that would require prolonged follow-up, we 
selected methyl salicylate, EPP, and croton oil as mild irritants 
for studies of the components of irritant reactions. Doses of each 
irritant that produced a moderate degree of inflammation were 
used: 5 mg methyl salicylate, 2 mg EPP, and 0.05 mg croton oil. 
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HISTOLOGY 
Cellular infiltration was evaluated by histology of various phases 
of the reactions to each irritant [9]. Two 6-J.tm hematoxy­
lin/eosin-stained nons erial sections of ears from 3 animals for 
each time point were examined. At 125 X, the number of blood 
vessels visible, their general condition (i.e., engorged with cells), 
and prominent features of the reaction were evaluated. Degree of 
edema, location, and type of cellular infiltrate, including the num­
ber of granulocytes, lymphocytes, monocytes, and eosinophils 
in 1 field at ear margin, one field in the middorsal area, and 2 
fields in the mid ventral area, and the condition of epidermis, 
dermis, lymphatics, and musculature of the ear were evaluated 
at 500 X. 
Microscopically, the lesions produced by each chemical differed 
in the time course of the development of edema, cellular infil­
trates, and vessel dilation (Table II). Within 20 min, methyl sa­
licylate produced rapid dilation of blood vessels, vessels at the 
margin of the ear became prominent, and moderate edema had 
developed. Within 1 h, tissue edema was regressing but vessels 
remained dilated. 
Ears treated with croton oil became edematous within 1 h; 
however, there was no increase in the number of visible blood 
vessels. Increased numbers of blood vessels were visible 6 h after 
croton oil application, edema was moderate to severe, and a dif­
fuse and vascular cellular infiltrate had developed. Based on the 
number visible, vessels at the ear margin were not dilated. 
At 1 h, vessels of ears treated with EPP were dilated and en­
gorged, especially those at the ear margin; edema was slight to 
moderate, and neutrophils were observed in blood vessels. By 8 
h, there was a large increase in the number of visible blood vessels, 
edema was severe, and a vascular and diffuse cellular infiltrate 
had developed. 
VASCULAR PERMEABILITY 
Vascular permeability to serum proteins was evaluated with try­
pan blue and iodine-labeled bovine serum albumin C25I-BSA). 
Initially, groups of mice were injected with trypan blue to de­
termine time points for 125I_BSA studies. Additional groups of 
animals were then injected with 1 J.tCi 125I_BSA in 0.1 ml saline, 
sacrificed after 15 min, and counts per minute (cpm) of inflamed 
and control ears of each animal were measured [9]. Trypan blue 
studies confirmed the pattern of regional involvement of blood 
vessels observed by histology. During the early periods of perme­
ability produced by EPP and methyl salicylate, only the margin 
Table II. Summary of Histologic Findings 
Number of 
Irritant Vessels" Neutrophils 
Control ears 22 ± 6 8 ± 3 
Methyl salicylate 
20 min 36 ± 14 11 ± 2 
1 h 42 ± 11 18 ± 1 
Croton oil 
1 h 22 ± 5 18 ± 4 
6 h  48 ± 13 90 ± 36 
Ethyl phenylpropiolate 
1 h 38 ± 14 35 ± 20 
8 h  6 5  ± 22 78 ± 16 
Inflammatory Cells" 
Monocytes 
6 ± 4 
9 ± 1 
9 ± 3 
9 ± 6 
29 ± 7 
18 ± 4 
32 ± 24 
Lymphocytes 
4 ± 3 
3 ± 
1 ± 
3 ± 4 
11 ± 9 
9 ± 4 
9 ± 3 
Degree of 
Edema 
Moderate 
Slight 
Slight 
Severe 
Moderate 
Severe 
"The number of blood vessels visible at 125 X were counted as an index of vessel dilation. The mean and standard deviation of the number of visible vessels per section 
are shown. 
"Cells of each type were counted in four high-power (500 X) fields of the same sections; the mean and standard deviation of the number of each cell type in each section 
are listed. Eosinsophils were also counted; however, too few were seen to summarize. 
VOL. 88, NO. 3 MARCH SUPPLEMENT 1987 
240 
160 
2 4 
Melhyl Salicylale 
6 8 10 
Time (h) 
12 
Figure 2. Time courses of 1251_BSA leakage. Mice were given 1 p.Ci 1251_ 
BSA intravenously at various times after application of 0.5 mg croton 
oil, 2 mg ethyl phenylpropiolate, or 5 mg methyl salicylate to one ear. 
Mice were sacrificed 15 min after injection, and the radioactivity (cpm) 
in both the irritant- and solvent-treated control ears was measured. The 
significance of differences between inflamed and control ears was eval­
uated by paired I-tests. The mean difference ± SD are shown. /I = 4-6 
for each data point. 
*p value of 0.005; +p value of <0.005. All other differences insignificant 
(p value >0.05). 
of the ear became blued; leakage was not apparent in the center 
of the ear. Generalized bluing of the entire ear developed during 
all other periods of leakage. The cpm of treated minus control 
ears for each time point are shown in Fig 2. Vessel permeability 
of ears treated with methyl salicylate increased within 2 min. The 
1S-min period after application of methyl salicylate was the period 
of greatest permeability. Vessel permeability rapidly approached 
normal values within 30 min of application of the compound. 
The permeability response between 8 and 12 h was less intense. 
The most intense period of vascular leakage after application 
of croton oil occurred between 8 and 12 h after application of 
croton oil. Only a modest increase in permeability was observed 
at 3 h, during the period of generalized bluing. The difference in 
cpm of treated and untreated ears was somewhat elevated at 4, 
6 ,  and 8 h. 
The early period of increased permeability after application of 
EPP began after application and continued through 6 0  min; leak­
age was most intense between 0 and 30 min. I25I-BSA leakage 
was also apparent at 4 and 6 h after application. The delayed 
permeability response at 8 and 10 h was almost as intense as the 
early permeability response. 
BLOOD FLOW 
Changes in blood flow were estimated as change in surface tem­
perature measured with a noncontact infrared temperature sensor 
[9]. Since environmental temperature and excitement may cause 
variation in blood flow, studies were conducted at constant tem­
perature, mice were preconditioned to the measurement proce­
dure, and differences in temperature of treated and untreated ears 
were compared. Time course, duration, and intensity of the changes 
differed for each chemical (Fig 3) . Temperature of ears treated 
with methyl salicylate increased rapidly, reached a maximum S 
min after application, and then decreased rapidly. This maximum 
4 
3 
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Figure 3. Time course of changes in local blood flow. Local changes in 
blood flow were estimated by comparing surface temperature of irritant­
and solvent-treated control ears. Temperature was measured with a non­
contact infrared temperature sensor. The significance of the temperature 
differences was evaluated by paired I-tests. 
*p value of <0.005; + P value of <0.05. All other differences insignificant 
(p value >0.05). /I = 6 for each group. Mean temperature differences 
± SD are shown. 
corresponded in time with the increase in vascular permeability 
and preceded the peak increase in ear thickness. 
Ears treated with croton oil developed the largest and most 
long-lasting change in blood flow. The surface temperature of 
ears treated with croton oil increased slowly, reaching a maximum 
2 h after application, and remained elevated during the period of 
increased permeability. Temperature decreased between 3 and 6 
h but was still somewhat elevated at the 6 -h peak of ear thickness. 
Ears treated with EPP developed triphasic changes in surface 
temperature. The first increase in blood flow developed rapidly 
to a maximum 30 min after application of EPP. Temperature 
remained elevated through 90 min, encompassing both the small 
peak in ear thickness and the first period of increased permeability. 
A smaller increase plateaued at 4 h and included a period of 
generalized vascular leakage. The third and largest change in tem­
perature occurred at 8 h, when EPP-induced ear thickness was 
maximal. 
Studies of blood flow and permeability showed that those com­
ponents are phasic in nature, that different numbers of periods of 
increased vessel reactivity develop in response to the 3 irritants, 
and that the periods of increased vascular reactivity do not occur 
at the same relative time in the inflammatory response to the 3 
irritants, i. e. , increased permeability to proteins is not the first 
vascular response to all irritants. Histology of the response shows 
that cellular infiltration did not develop before maximum ear 
thickness for 1 irritant. Those findings demonstrate that the re­
sponses to those topically applied irritants can not be accurately 
described as identical processes developing at different rates. 
MEDIATORS 
Agents producing vessel dilation, increasing vascular permeabil­
ity, acting as chemoattractants for inflammatory cells, or directly 
damaging cell membranes may serve as mediators of inflamma-
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Table III. Agents and Dosage Regimens Used to Study Mediator Involvement 
Putative Mediator Treatment/Dosage Regimen' Method of Anti-inflammatory Effect 
Histamine 1 mg/kg cimetidine, s.c.; 30 min, 3 h, 6 h Antagonist at H2 receptors 
Antagonist at HI receptors 
Antagonist at peripheral receptors 
Inhibits synthesis 
5-Hydroxytryptamine 
Prostaglandins 
1.5 mg/kg mepyramine maleate, s.c.; 30 min, 3 h, 6 h 
1 mg/kg methysergide maleate, s.c.; 30 min, 3 h, 6 h 
I, 3 mg/kg indomethacin, oral; 30 min, 6 h 
Kinins 
Complement 
Neutrophil Products 
22 mg/kg aprotinin, i.v.; 15 min, 2 h, 4 h, 6 h 
12 p.g cobra venom factor, i.p.; 46 h 
Inhibits synthesis 
Depletes components 3, 5, 6, 7, 8, and 9 
Produces neutropenia 60 p.g mechlorethamine, i.v.; 96 h 
• Application of the irritant to the ear was considered time O. The doses listed were given at each time listed. Drugs were solubilized in saline for all injections; indomethacin 
was suspended in water. Control animals were given injections or water of equal volumes at the same time points. 
tory responses. During the last 50 years, many autocoids pro­
ducing these effects have been identified. In 1973, Van Arman 
reviewed what was known about mediators of skin inflammation 
and summarized the popular approach for investigating inflam­
mation as follows: 
"Over several decades, investigators have attempted to fix a large 
share of the blame for inflammation upon certain mediators. His­
tamine, leukotaxin, bradykinin, serotonin, the prostaglandins­
all have been incriminated in turn. Surely some of these play 
minor supporting roles in the drama." [15] 
Although new putative mediators have been added to the list, 
no agent has as yet met all the criteria to establish it as a mediator 
of skin irritation [16]. Agents partially meeting the criteria as 
mediators of skin irritation include histamine, prostaglandins, 
kinins, products released by neutrophils, leukotrienes, comple­
ment, Hageman factor, plasmin, 5-hydroxytryptamine, and epi­
dermal factors. 
Agents that block the pharmacologic effect of a putative me­
diator by acting as antagonists at the site of action, by inhibiting 
synthesis of the mediator, or by depleting the skin of the animal 
of the mediator can be used to demonstrate the involvement of 
putative mediators in a response. Involvement of 6 putative me­
diators in chemically induced irritant inflammation was evaluated 
in our studies [10]. The approaches that were used were based 
on published information of the action of specific agents. Dosing 
regimens (Table III) were based on published information of half­
life of the drug and the therapeutic dose for other inflammatory 
conditions or were determined in this model. 
The statistical significance of differences in the ear thickness 
responses of mice treated with an agent to block the effect of a 
putative mediator and of age-matched control animals was cal­
culated by Student's t-test. The estimate of the sample standard 
deviation (n - 1) was used for the analysis. A p value of <0.05 
was considered statistically significant. Because ear thickness mea­
surements at the various time points are not independent vari­
ables, only differences at points of inflammatory maximums were 
initially considered. Calculations were made for p values of dif­
ferences 15 min after application of methyl salicylate, 1 and 8 h 
after application of EPP, and 6 h after application of croton oil 
(Table IV). The time at which differences between responses of 
pretreated and control groups became significantly different was 
then determined to evaluate the probable role of the putative 
mediator and to confirm the mode of action of the pretreatment. 
METHYL SALICYLATE 
Indomethacin and aprotinin significantly suppressed the devel­
opment of increased ear thickness after application of methyl 
salicylate, suggesting that prostaglandins and kinins are mediators 
of the response. The inflammatory response to methyl salicylate 
was primarily vascular. Blood flow and permeability increased 
within minutes of application. Intradermal injection of PGE 
produces increases blood flow [17], and injection of bradykinin 
relaxes peripheral arteriolar smooth muscle, leading to increased 
blood flow and increased capillary permeability [17,18]. In ad­
dition, it has been shown that simultaneous injection of brady-
kinin and prostaglandin potentiates the vascular effects of the 
agents [17]. If this potentiation occurs for endogenously generated 
mediators, the effect of bradykinin and prostaglandins may be 
greater than that suggested by the degree of suppression produced 
by aprotinin and indomethacin. All other treatment regimens 
failed to suppress methyl salicylate-induced inflammation. 
ETHYL PHENYLPROPIOLATE 
The 1-h ear thickness response was partially suppressed by pre­
treatment with indomethacin, aprotinin, and mechlorethamine. 
Almost immediately after application of EPP, vascular permea­
bility increased; blood flow increased somewhat more slowly. As 
in the case of methyl salicylate, the combined actions of kinins 
and prostaglandins on vascular permeability seemed to be in­
volved early in the EPP response. Changes in blood flow in the 
first 90 min after application of EPP cannot be explained as sim­
ply, because the increase in blood flow was much more prolonged 
than the blood flow response to methyl salicylate. Because me­
chlorethamine partially suppressed the �ar thickness response dur­
ing this period and the number of inflammatory cells in the tissue 
had increased, it is possible that immigrating cells provided a new 
source of mediators that contributed to the modulation of blood 
flow [22]. Polymorphonuclear cells are a rich source of prosta­
glandins [23] as well as lysosomal enzymes [24] and biologically 
active oxygen species [25]. 
A second period of increased vascular permeability and in­
creased blood flow occurred 2-4 h after application of EPP. Sup­
pressive effects of the antihistamines, methysergide maleate, and 
cobra venom factor (CVF) became apparent at the 4-h thickness 
measurement. Both histamine [26-28] and 5-hydroxytryptamine 
(5-HT) [29] have been shown to produce vascular changes and 
could have been released from mast cells because, in the mouse, 
mast cell granules contain both histamine and 5-HT [29,30]. Be­
cause involvement of histamine and 5-HT was not detected until 
4 h after application of EPP, it seems unlikely that the irritant 
directly caused degranulation of mast cells. Complement acti­
vation produces molecules that can cause degranulation of mast 
cells [31-33] and that are chemotactic to neutrophils [34,35]. A 
portion of the suppression of EPP inflammation produced by 
pretreatment with CVF could have been due to fewer neutrophils 
migrating into the area. 
Blood flow and vascular permeability were both increased 8 h 
after application of EPP. All 6 pretreatments p'artially suppressed 
the inflammatory response to EPP at 8 h; however, because 
suppression of one phase of the response may reduce subsequent 
measurements, it is not possible to conclude which putative me­
diators were responsible for these changes. 
CROTON OIL 
At 6 h, the response to croton oil was partially suppressed by 
aprotinin, 3 mg/kg indomethacin, and mechlorethamine. The 
earliest event in the response to croton oil was the gradual increase 
in blood flow, which reached maximum between 2 and 3 h. 
Inflammatory cells were also infiltrating the area during this time. 
Only a small increase in vascular permeability was observed be­
tween 2.5 and 3 h. Pretreatment with aprotinin partially sup-
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Table IV. Effect of Pharmacologic Agents on Ear Thickness Responses to Methyl Salicylate, 
Ethyl Phenylpropiolate, and Croton Oil 
Increased Ear Increased Ear 
Thickness; Thickness; 
Controls Experimental 
Pretreatment" Irritantb (mm)' Mice (mm)' Significanced 
Antihistamines Methyl salicylate 0.131 0.13 0.5 
EPP 1 h 0.303 0.287 >0.2 
8h 0.371 0.233 <0.005 
Croton oil 0.33 0.356 0.5 
Methysergide maleate Methyl salicylate 0.125 0.15 >0.1 
EPP 1 h 0.187 0.218 0.5 
8h 0.328 0.217 <0.005 
Croton oil 0.323 0.267 >0.1 
Indomethacin (3 mg/kg) Methyl salicylate 0.131 0.08 <0.05 
EPP 1 h 0.303 0.223 <0.01 
8h 0.371 0.169 <0.001 
Croton oil 0.33 0.202 <0.02 
Indomethacin (1 mg/kg) Methyl salicylate 0.131 0.092 <0.05 
EPP 1 h 0.303 0.212 <0.01 
8 h 0.371 0.156 <0.001 
Croton oil 0.33 0.22 >0.1 
Aprotinin Methyl salicylate 0.115 0.047 <0.002 
EPP 1 h 0.161 0.067 <0.002 
8h 0.360 0.212 <0.005 
Croton oil 0.347 0.227 <0.002 
Cobra venom factor Methyl salicylate 0.91 0.105 0.5 
EPP 1 h 0.164 0.151 0.5 
8 h 0.340 0.232 <0.02 
Croton oil 0.357 0.314 >0.1 
Mechlorethamine Methyl salicylate 0.134 0.139 0.5 
EPP 1 h 0.228 0.14 <0.002 
8h 0.355 0.150 <0.001 
Croton oil 0.33 0.202 <0.005 
'Dosing regimens are given in Table III. 
'Either 5 mg methyl salicylate, 2 mg ethyl phenylpropiolate (EPP), or 0.5 mg croton oil in 10 ILl acetone or ethanol was applied to one ear of each animal. The solvent 
was applied to the opposite ear. 
'Values shown are differences between mean ear thickness at the time of maximum ear thickness and mean ear thickness of the same _group before application of the 
irritant. " = 9-10 for groups treated with cobra venom factor or mechlorethamine; n = � all other groups. 
ip values were calculated by I-test using the sample standard deviation (n - 1). A difference of <0.05 was considered significant. 
pressed the increase in ear thickness between application and the 
2-h and 4-h thickness measurements. Because bradykinin is a very 
potent mediator of vascular permeability [36], it seems unlikely 
that bradykinin could be formed without producing a detectable 
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Figure 4. The effect of indomethacin on inflammatory responses to ethyl 
phenylpropiolate and croton oil. Mean ear thickness ± SD of (e) control, 
(.6.) mice given 1 mg/kg indomethacin at - 30 min and at 6 h, and (0) 
mice given 3 mg/kg indomethacin at - 30 min after application of ethyl 
phenylpropiolate or croton oil are shown. Both doses of indomethacin 
were equally effective in suppressing responses to ethyl phenylpropiolate 
and methyl salicylate (not shown) and the early response to croton oil. 
At 6 h, the difference in response of (.6.) 1 mg/kg indomethacin-treated 
and (e) control animals to croton oil was not significant and the ear 
thickness of (.6.) animals remained elevated through 12 h. 
increase in permeability. However, aprotinin also inhibits trypsin 
and enzyme proteases released by neutrophils [37-39]. The apro­
tinin suppression of croton oil-induced increases in ear thickness 
may involve inhibition of enzymes other than kallikrein. 
Early in the development of the croton oil response, 1 and 3 
mg/kg indomethacin were equally effective in suppression of the 
response, although only the high dose of indomethacin produced 
permanent suppression of the response (Fig 4). This suggests 
indomethacin may have produced its effects by multiple mech­
anisms: inhibition of prostaglandin synthesis at the therapeutic 
dose of 1 mg/kg [40] and the inhibition of phagocyte motility 
[25,41] or inhibition of generation of mediators produced by 
phagocytes [41,42]. The sustained increase in blood flow was 
probably produced by prostaglandins, because few other media­
tors produce vasodilation and increased blood flow with little or 
no effect on vascular permeability to proteins. 
Mechlorethanime significantly reduced the response to croton 
oil, and the role of inflammatory cells seems crucial to this re­
sponse. Since there was no significant leakage of plasma proteins, 
vascular permeability to proteins contributed very little to edema 
formation before the 6-h evaluation. The increased blood flow of 
the croton oil response could account for the edema formed [43,44] 
between 0 and 4 h. However, fluid would rapidly be cleared 
through the lymphatics or be reabsorbed by the venous circulation 
unless other factors had increased either tissue oncotic or osmotic 
pressure [44]. Release of lysosomal enzymes by phagocytes, and 
the subsequent cellular damage they produce is one possible ex­
planation of the tissue's ability to retain fluid in the absence of 
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leakage of plasma proteins. Proteins normally not contributing 
to tissue oncotic pressure would be released into the interstitial 
compartment and cause fluid retention. This hypothesis could 
also explain the effect of aprotinin in the croton oil response; 
inhibition of lysosomal enzymes by aprotinin could decrease cel­
lular damage and therefore reduce fluid retention. 
SUMMARY 
All mediators of the irritant responses to methyl salicylate, EPP, 
and croton oil may not have been identified in these studies and 
it is not possible to completely describe the mechanisms of these 
inflammatory responses; however, these studies have provided 
convincing evidence that there are basic differences in the inflam­
matory processes triggered by irritants. The true significance of 
these observations will be known only with time. A number of 
areas for future research seem apparent. Is the poor interspecies 
correlation of skin irritation related to differences in mediator 
sensitivity, levels, etc. that may magnify differences in inflam­
matory mechanisms? Does mechanism determine which chemi­
cals produce "cumulative irritation" or "hardening" and can 
mechanism/time course and mediator studies of the type used in 
our studies be used to explain the biologic basis of these responses? 
Can differences in mechanism be used to explore the mechanisms 
by which topical steroids exert their effects? What is the biologic 
effect of combining irritants acting by different mechanisms? Is 
irritant inflammation a separable event from permanent tissue 
damage and can in vitro assays for corrosive materials be devel­
oped based on that separation? Can the difference in mechanisms 
of responses to various irritants be used to probe the mechanisms 
of dermatologic conditions such as the excited skin syndrome, 
Koebner phenomenon, and atopy? 
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